碘番酸配合^（131）I疗治甲亢  

Management of Hyperthyroidism with Iopanoic Acid before ￣(131)I Treatment

作　　者：潘明志[1] 管昌田[1] 

机构地区：[1]华西医科大学附属第一医院核医学科

出　　处：《华西医学》1994年第2期174-176,共3页West China Medical Journal

摘　　要：对拟用^（１３１）Ｉ治疗的中、重度Ｇｒａｖｅｓ病患者，用短程碘番酸口服（６天）作为治疗前准备，可减少^（１３１）Ｉ的治疗反应和迅速控制病情。本文资料表明：服碘番酸３天后，血中Ｔ３水平降低６９．０％，６天后Ｔ_４水平降低２６．７％，同时甲状腺吸碘率亦明显降低，但停药７天后即回复到服药前水平。揭示碘番酸是^（１３１）Ｉ治疗重度甲亢较好的辅助药物，停服碘番酸后７天是给予进一步（１３１）Ｉ治疗的较佳时间。patients with Graves'disease were treated by iopanoic acid before ￣(131)I treatment.There was a marked fall in T_3 levels by 69% of the pretherapy value hy 3 days and a fall in T_4 levels by 26.7% of the pretherapy value by 6 days with a decrease of thyroid ￣(131)I uptake rate. These data indicate that iopanoic aciel is a effective drug for high risk patients to be treated by ￣(131)I, that 7 days after stopping the drug is a good time for further ￣(131)I therapy.

关 键 词：碘番酸 碘131 甲亢 

分 类 号：R581.105[医药卫生—内分泌]